Asosiy kontentga oʻtish
AkademIndex

Xizmatlar

← Ishga qaytish

Ushbu ish iqtibos qilgan ishlar

122 ta ish

Ish: Pharmacomicrobiomics in blood cancers: How the gut microbiome and its metabolites shape drug efficacy and toxicity

  1. Precisely Tailoring Molecular Structure of Doxorubicin Prodrugs to Enable Stable Nanoassembly, Rapid Activation, and Potent Antitumor Effect

    Chengcheng Feng, Yuting Wang, Jinghua Xu +5

    MaqolaOchiq kirish202412 iqtibos
    ABI

  2. Unlocking the full potential of memory T cells in adoptive T cell therapy for hematologic malignancies

    Ding-Ya Sun, Yijie Hu, Xin Li +3

    Sharh maqola202412 iqtibos
    ABI

  3. Disorders of cancer metabolism: The therapeutic potential of cannabinoids

    Dingya Sun, Xin Li, Shengdan Nie +2

    Sharh maqolaOchiq kirish20229 iqtibos
    ABI

  4. Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients

    Vancheswaran Gopalakrishnan, C. N. Spencer, Luigi Nezi +67

    Maqola20177 iqtibos
    ABI

  5. Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy

    Lukas F. Mager, Regula Burkhard, Nicola Pett +10

    Maqola20205 iqtibos
    ABI

  6. Simultaneous quantification of mirabegron and vibegron in human plasma by HPLC-MS/MS and its application in the clinical determination in patients with tumors associated with overactive bladder

    Yutao Lou, Mengting Cheng, Qin Cao +7

    Maqola20235 iqtibos
    ABI

  7. Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors

    Bertrand Routy, Emmanuelle Le Chatelier, Lisa Derosa +45

    Maqola20175 iqtibos
    ABI

  8. Fecal 16S rRNA sequencing and multi-compartment metabolomics revealed gut microbiota and metabolites interactions in APP/PS1 mice

    Xin Cheng, Yejun Tan, Hongli Li +8

    Maqola20225 iqtibos
    ABI

  9. Gut microbiome–derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease

    Nathan D. Mathewson, Robert R. Jenq, Anna V. Mathew +18

    MaqolaOchiq kirish20164 iqtibos
    ABI

  10. Assessing the Performance of Prediction Models

    Ewout W. Steyerberg, Andrew J. Vickers, Nancy R. Cook +5

    Maqola20094 iqtibos
    ABI

  11. Role of gut microbiome in cancer immunotherapy: from predictive biomarker to therapeutic target

    Mengwei Zhang, Jinkai Liu, Qiang Xia

    Sharh maqola20233 iqtibos
    ABI

  12. Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients

    Erez N. Baruch, Ilan Youngster, Guy Ben‐Betzalel +29

    Maqola20203 iqtibos
    ABI

  13. Fecal microbiota transplant overcomes resistance to anti–PD-1 therapy in melanoma patients

    Diwakar Davar, Amiran Dzutsev, John A. McCulloch +29

    Maqola20213 iqtibos
    ABI

  14. The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation

    Ying Taur, Robert R. Jenq, Miguel‐Angel Perales +12

    Maqola20143 iqtibos
    ABI

  15. Toll-like Receptors on Hematopoietic Progenitor Cells Stimulate Innate Immune System Replenishment

    Yoshinori Nagai, Karla P. Garrett, Shoichiro Ohta +5

    Maqola20063 iqtibos
    ABI

  16. Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme

    Bret D. Wallace, Hongwei Wang, Kimberly T. Lane +8

    Maqola20103 iqtibos
    ABI

  17. Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects

    Romain Daillère, Marie Vétizou, Nadine Waldschmitt +33

    Maqola20163 iqtibos
    ABI

  18. The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication

    Ygor Parladore Silva, Andressa Bernardi, Rudimar Luiz Frozza

    Sharh maqola20203 iqtibos
    ABI

  19. Targeted inhibition of gut bacterial β-glucuronidase activity enhances anticancer drug efficacy

    Aadra P. Bhatt, Samuel J. Pellock, Kristen A. Biernat +16

    Maqola20203 iqtibos
    ABI

  20. The microbiota regulates hematopoietic stem cell fate decisions by controlling iron availability in bone marrow

    Dachuan Zhang, Xin Gao, Huihui Li +6

    Maqola20223 iqtibos
    ABI

  21. Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer

    Lisa Derosa, Bertrand Routy, Andrew Maltez Thomas +40

    Maqola20223 iqtibos
    ABI

  22. Gut microbiota shapes cancer immunotherapy responses

    Wanting Lei, Kexun Zhou, Ye Lei +2

    Sharh maqola20252 iqtibos
    ABI

  23. Sarlavhasiz

    Boshqa2 iqtibos
    ABI

  24. Comparative genomics of bacterial and plant folate synthesis and salvage: predictions and validations

    Valérie de Crécy‐Lagard, Basma El Yacoubi, Rocío de la Garza +2

    Maqola20072 iqtibos
    ABI

  25. Effect of polyglutamylation of methotrexate on its accumulation and the development of resistance in the protozoan parasite Leishmania

    Amal El Fadili, Dave Richard, Christoph Kündig +1

    Maqola20032 iqtibos
    ABI